iProgen Biotech Inc.
- Biotech or pharma, therapeutic R&D
iProgen offers proprietary, modular platforms that enhances both the antibody delivery to tumor cells and antibody-receptor internalization. The platform unlocks numerous receptors that were previously overlooked or not considered for ADC development.